Every year, more than 3,000 scientific abstracts are accepted for oral and poster presentation at the Society's annual meeting.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research
Advance registration for the 56th ASH® Annual Meeting is now open.
Featuring clinical hematology updates with a focus on lymphoid malignancies
ASH endorses a new evidence-based expert panel report on the management of sickle cell disease published by the National Heart, Lung, and Blood Institute (NHLBI)
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research.
Search a database of practicing hematologists in your area.
Help move hematology forward by supporting research, career development, and quality care and education programs.
Become part of a global network of more than 16,000 hematologists working to conquer blood diseases.
American Society of Hematology (ASH) today announced the names of the 21
hematology trainees selected to participate in the 12th annual ASH Clinical
Research Training Institute (CRTI).
This education and mentorship program is designed to prepare current hematology
and hematology/oncology fellows and junior faculty for careers in
patient-oriented clinical research.
The American Society of Hematology (ASH), the world's largest professional organization dedicated to the causes and treatments of blood disorders, today endorsed a new evidence-based expert panel report on the management of sickle cell disease published by the National Heart, Lung, and Blood Institute (NHLBI) aimed at improving the care of patients with sickle cell disease (SCD).
The American Society of Hematology (ASH) and the European Hematology Association (EHA) announce the names of 20 early-career
hematologists participating in the 2014 Translational Research Training in Hematology (TRTH) joint program.
The American Society of Hematology (ASH) today announced the names of 19 medical students and 10 residents selected to receive a 2014 ASH HONORS (Hematology Opportunities for the Next Generation of Research Scientists) Award.
ASH submitted comment
letters covering Medicare proposals for payments and associated policies for
services paid under the physician fee schedule and the hospital outpatient
prospective payment system.
Friday July 25, 2014, ASH and the American Society of Clinical Oncology (ASCO) co-hosted
the annual Hematology and Oncology Carrier Advisory Committee (CAC) network
meeting. The meeting is intended to provide attendees
with a better understanding of the CAC process; discuss issues of common
concern and develop solutions; and improve the overall CAC process throughout
June, ASH joined an effort to advocate that Medicare change recent rules that required Medicare patients
who had entered hospice status to go through prior authorization for all
prescription drugs. ASH and the other
organizations that worked on this issue felt that this requirement was a
significant hurdle to be faced by patients whose disease had necessitated
Dr. Bertuch and Dr. Kurre examine the need for improvement in how acquired aplastic anemia is both diagnosed and treated in the United States.
This fall, ASH will begin publishing a monthly news magazine specifically designed to appeal to clinical practitioners in hematology and oncology. ASH Clinical News will provide timely updates in the field by reporting on key medical meetings, clinical trials, innovative technology, and influential papers in the literature.
Dr. Gilbert White chronicles his involvement in the HIV and HCV epidemics that devastated the hemophilia population in the 1980s, highlighting the power of science and the resilience of patients, physicians, and scientists, who faced adversity and triumphed.
It's not to early to plan to attend the annual meeting. Read about what's in store for this year's program.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology